Soluble pityrosporum-derived chemoattractant for polymorphonuclear leukocytes of psoriatic patients

Acta Dermato-Venereologica

Volumn 76, Issue 1, 1996, Pages 10-12

  Bunse, Thomas ^a,b   Mahrle, Gustav ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b NONE   (Germany)

Author keywords

Atopic eczema; Boyden chamber; Chemotaxis

Indexed keywords

ADULT; ARTICLE; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NEUTROPHIL; PITYROSPORUM ORBICULARE; PRIORITY JOURNAL; PSORIASIS; STAPHYLOCOCCUS EPIDERMIDIS;

ADULT; CELL DIVISION; CHEMOTACTIC FACTORS; CHEMOTAXIS, LEUKOCYTE; DERMATITIS, ATOPIC; FEMALE; HUMANS; MALASSEZIA; MALE; MIDDLE AGED; NEUTROPHILS; PSORIASIS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 0029670248     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Faergemann J, Fredrikson T. Experimental infections in rabbits and humans with Pityrosporum orbiculare and P. ovale. J Invest Dermatol 1981; 77: 314-318.
2. Bäck O, Faergemann J, Hörnqvist R. Pityrosporum folliculitis: a common disease in the young and middle aged. J Am Acad Dermatol 1985; 12: 56-61.
3. Katoh T, Kagawa S, Ishimoto M. Malassezia intertrigo, a new clinical entity. Mycoses 1988; 31: 558-562.
4. Bergbrant I-M, Faergemann J. Seborrheic dermatitis and Pityrosporum ovale: a cultural and immunological study. Acta Derm Venereol (Stockh) 1989; 69: 332-335.
5. Bunse T, Mahrle G. Anthralin is a potent inhibitor of Pityrosporum orbiculare/ovale in vitro. Acta Derm Venereol (Stockh) 1992; 72: 72-73.
6. Lober CW, Belew PW, Rosenberg EQ, Bale G. Patch tests with killed sonicated microflora in patients with psoriasis. Arch Dermatol 1982; 118: 322-325.
7. Elewski B. Does Pityrosporum ovale have a role in psoriasis? Arch Dermatol 1990; 126: 1111-1112.
8. Bunse T, Mahrle G. Der Effekt von Anthralin auf die Hautbesiedelung von Psoriatikern mit Pityrosporum. Z Hautkr 1992; 67: 324-329.
9. Bergbrant I-M, Faergemann J. The role of Pityrosporum ovale in seborrheic dermatitis. Semin Dermatol 1990; 9: 262-268.
10. Broberg A, Faergemann J, Johansson S, Johansson SGO, Strannegård I-L, Svejgaard E. Pityrosporum ovale and atopic dermatitis in children and young adults. Acta Derm Venereol (Stockh) 1992; 72: 187-192.
11. Langner A, Chorzelski TP, Fraczkowska G, Jablonska S, Szymanczyk J. Is chemotactic activity in polymorphonuclear leukocytes increased in psoriasis? Arch Dermatol Res 1983; 275: 226-228.
12. Wahba A, Cohen HA, Bar-Eli M, Gallily R. Enhanced chemotactic and phagocytic activities of leukocytes in psoriasis vulgaris. J Invest Dermatol 1978; 71: 186-188.
13. Green CM, Ferguson J, MacLeod TM, Millar BW, Raffle EJ. Polymorphonuclear leucocyte chemotaxis in response to leukotriene B4 in treated and untreated psoriatics. Dermatologica 1989; 178: 20-22.
14. Scheja A, Bruze M, Forsgren A. Leukocyte migration in vivo and in vitro in patients with psoriasis. Acta Derm Venereol (Stockh) 1987; 67: 427-432.
15. Guillor B, Coupe M, Alirezai M, Bureau JP, Giulhou JJ. Studies of polymorphonuclear migration into psoriatic skin using a new in vivo method. Arch Dermatol Res 1989; 280: 477-480.
16. van de Kerkhof PCM, Chang A. Migration of polymorphonuclear leukocytes in psoriasis. Skin Pharmacol 1989; 2: 138-154.
17. Isoda M. Leukocyte chemotactic activity and circulating immune complexes in psoriasis. J Dermatol 1987; 14: 576-579.
18. Lammers AM, van de Kerkhof PCM. Response of polymorphonuclear leukocytes to topical leukotriene B4 in healthy and psoriatic skin. Br J Dermalol 1987; 116: 521-524.